VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (AD), today announced its corporate presentation, which can be found on the company web site, has been revised to include an update on the progress of its collaboration with Eli Lilly and Company (NYSE:LLY).
